22 patents
Page 2 of 2
Utility
Methods of Treating Immunotherapy-related Toxicity Using a GM-CSF Antagonist
6 Nov 19
Methods for reducing relapse rate or preventing occurrence of tumor relapse in a subject treated with immunotherapy, in an absence of an incidence of immunotherapy-related toxicity or in a presence of immunotherapy-related toxicity.
Cameron DURRANT, Dale Chappell
Filed: 14 Jan 19
Utility
Methods of Treating Immunotherapy-related Toxicity Using a GM-CSF Antagonist
23 Oct 19
Methods for reducing blood-brain barrier disruption in a subject treated with immunotherapy, the method comprising administering a recombinant GM-CSF antagonist to the subject.
Cameron Durrant, Dale CHAPPELL
Filed: 21 Feb 19